Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line
Corcept Therapeutics Inc. CORT reported adjusted fourth-quarter 2018 earnings of 24 cents per share, beating the Zacks Consensus Estimate of 21 cents. The bottom line also improved from the year-ago quarter’s figure of 19 cents on higher revenues […]